Indian API exporters have risen to support the global diabetic drug market by 57%, with FDA & WHO-approved APIs powered by Government Production Linked Incentives, a skilled workforce, and innovation. The market shift from conventional insulin to premium patient-compliant dosages and growth in the diabetic population have opened up the scope.
Hence, Jatan Exports, an Indian API exporter, is ready with basic GLP-1 to dual GIP receptors comprising Empagliflozin, Metformin, Sitagliptin, Semaglutide, and Tirzepatide to serve the global buyers. We power up the global diabetic drug market for end dosage makers with multiple APIs, bulk shipment, relevant incoterms, and rock-bottom prices.
What is India’s position in the global diabetic API supply chain?
India accounts for 30% of the global production of diabetic API, maintaining a strong supply chain. Some of the key factors facilitating a premium quality production process and coherent demand are:
- AI-driven peptide synthesis process
- High-precision purification process
- Free drawing or advanced lyophilization process
- Total stability studies
- Maximum production units certified by the USFDA & the EU
Moreover, diabetes drug API manufacturers in India are facilitated by the following to serve the international demand with efficacy and comprehensiveness due to the following factors:
- Skilled workforce
- Favourable geographical conditions
- Government schemes
- Competent cost manufacturing process
- Adherence to compliance
- Logistic infrastructure
- Scientific and clinical research
How India made diabetic API help global buyers?
India-made API helps the global diabetes drug market by providing HPLC with more than or equal to 98% of the ICH-approved limit of controlled impurities. Besides, they provide a standard CDMO process with stage-wise scaling-up, consistent stability data by ICH zone, and packaging. Industry-standard protocols are applied for tech transfer with proper regulatory compliance like DMF filing, GMP, ESG, and QMS certifications.
These facilities enable buyers to get easy compliance with registration or regulations in specific countries. Also, Indian API exporters like Jatan Exports provide long-term contracts with less negotiation and a comprehensive range of consistent supply.
Top 5 diabetic API exported from India
Here is a list of diabetic API majorly exported from India. However, among those, Jatan Exports is a high-volume Metformin API exporter in India; moreover, we have 30+ API with GMP, EP, and DMF support.
- Empagliflozin
- Sitagliptin
- Dapagliflozin
- Linagliptin
- Vildagliptin
We have multiple sources or Indian manufacturers as our suppliers to meet the target price and necessary specifications all under one roof. Our range of excipients and pallets enables buyers to get a full package of raw materials in combined shipments in a preferred incoterm at any port across the world.
Rising global demand for diabetes medication
Awareness, education, and lifestyle disorders lead to a rise in diabetic patients; hence, the global demand for API to make medicine dosages. Besides, obesity and metabolic disorders are enhancing growth factors for demand. There is exponential growth in overall Indian pharma API exports in 2026, and diabetic API has a great part in that ratio. Our country is the third highest supplier with all regulatory documents, quality reports, data, and services. Apart from insulin, generic diabetes drug manufacturing companies can also buy API from Jatan Exports.
We are not just an Indian API exporter; we have a team of experts powered by renowned laboratories in India to analyse the documents and quality of material. We offer an audit facility to buyers at no added cost. Simultaneously, we aim to increase awareness about various diseases and symptoms so that it helps to reduces disseses. We aim at a healthy generation where people are aware about ailments and know about the drug and its making. This helps the entire world population with sharing of knowledge and care.
Leave a Reply